Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myelodysplastic Syndromes 1478Leukemia, Myeloid, Acute 1239Leukemia, Myelogenous, Chronic, BCR-ABL Positive 863Leukemia 745Precursor Cell Lymphoblastic Leukemia-Lymphoma 704Myeloproliferative Disorders 631Leukemia, Myelomonocytic, Chronic 455Lymphoma, Non-Hodgkin 447Primary Myelofibrosis 430Multiple Myeloma 423Leukemia, Lymphocytic, Chronic, B-Cell 408Hodgkin Disease 384Lymphoma 343Leukemia, Myeloid, Chronic-Phase 335Blast Crisis 282Polycythemia Vera 267Leukemia, Myeloid, Accelerated Phase 263Lymphoma, Follicular 254Lymphoma, Mantle-Cell 253Burkitt Lymphoma 246Lymphoma, Large B-Cell, Diffuse 244Lymphoma, B-Cell, Marginal Zone 225Congenital Abnormalities 215Lymphoma, Large-Cell, Immunoblastic 201Myelodysplastic-Myeloproliferative Diseases 199Thrombocythemia, Essential 197Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 196Anemia, Refractory, with Excess of Blasts 194Hematologic Neoplasms 193Neoplasms, Plasma Cell 184

Interventions

luspatercept 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Higher-risk Myelodysplastic Syndrome × Myeloid × Clear all
NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

Peking Union Medical College Hospital

Phase 3 Not yet recruiting
86 enrolled
Myeloid

Higher-risk Myelodysplastic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡